(Q40482489)

20 September 2017

title

IGSF4 promoter methylation and expression silencing in human cervical cancer. (English)

1 reference

20 September 2017

Jianduan Li

1

1 reference

20 September 2017

Zhengyan Zhang

2

1 reference

20 September 2017

Miri Bidder

3

1 reference

20 September 2017

Margo C Funk

4

1 reference

20 September 2017

Loan Nguyen

5

1 reference

20 September 2017

Paul J Goodfellow

6

1 reference

20 September 2017

Janet S Rader

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

96

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

150-158

1 reference

Suppression of malignancy in human cells

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Hypermethylation of the TSLC1 Gene Promoter in Primary Gastric Cancers and Gastric Cancer Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5'-end of the GSTP1 CpG island

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Sp1 elements protect a CpG island from de novo methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Epigenetic gene inactivation induced by a cis-acting methylation center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

Effects of methylation on expression of TMS1/ASC in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.050

10.1016/J.YGYNO.2004.08.050

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference